Form D · Other Health Care
Epikast Inc.
Brooklyn, NY · CIK 0001967033
Offering snapshot reported Feb 5, 2026 · SEC filing
- Reported sold
- $700K Offering amount: $2.2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jan 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2026 | Initial | $700,000 | No comparison | 2 | SEC filing |
| Feb 28, 2023 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572449
Source: Form D, filed Feb 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daphne Karydas | Director |
| Oleg Nodelman | Director |
| Stelios Papadopoulos | Director |
| Dimitrios Papalexopoulos | Director |
| Brad Prosek | Director |
| Alexandros Tzoukas | Director |
| Evangelos Vergetis | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
370 Jay Street 7th Floor
Brooklyn, NY, 11201
Brooklyn, NY, 11201